ADAR1 Capital Management, LLC
Top Portfolio Positions
283 positions ·
$1,622,497,451 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ABVX |
Abivax S.A.
Healthcare
|
1,438,019 | $160,123,415 | 9.87% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
994,119 | $104,780,142 | 6.46% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
3,285,906 | $91,019,596 | 5.61% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
2,679,010 | $66,546,608 | 4.10% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
1,114,699 | $58,766,931 | 3.62% | |
| SPY |
Spdr S&P 500 ETF Trust
|
75,940 | $49,386,819 | 3.04% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
632,556 | $41,691,765 | 2.57% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
1,139,331 | $41,380,501 | 2.55% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
1,871,455 | $35,931,936 | 2.21% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
1,446,375 | $34,467,116 | 2.12% |
Portfolio Trend
10 quarters · across all stocks
Holdings in MLYS
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,190,443 | 154,686 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $4,943,822 | 136,231 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,966,784 | 78,238 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,087,751 | 302,125 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,183,189 | 263,425 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,359,369 | 841,541 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,833,046 | 729,401 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $296,782 | 25,366 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $309,840 | 24,000 | Shares | Sole | 2024-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||